Articles related to PROSTATE CANCER

In a population-based trial, MRI-targeted biopsy significantly reduced the detection of clinically insignificant prostate cancer compared to systematic biopsy, without increasing the risk of advanced cancer detection. These findings support the use of MRI-targeted biopsy as a more efficient and safer screening method.

Prostate cancer screening guidelines that use race as a criterion are under ethical scrutiny, with experts calling for a shift towards universal, unbiased risk assessment that addresses socioeconomic factors and healthcare access disparities.

This refined surgical technique for robotic-assisted laparoscopic radical prostatectomy focuses on preserving vital supportive structures while effectively removing the prostate, potentially enhancing post-operative outcomes.

Recent research suggests that transperineal prostate biopsies can be safely performed without antibiotics, potentially offering an alternative to traditional transrectal biopsies for cancer detection and monitoring.

MacroGenics’ Phase II TAMARACK trial for vobramitamab duocarmazine in metastatic prostate cancer reported five patient deaths, raising critical safety concerns but also highlighting promising response rates that could influence future treatment protocols.

Interim results from J&J’s Phase I study of JNJ-6420 highlight both promising efficacy in prostate cancer treatment and serious safety concerns, with 60% of patients experiencing severe adverse events.